8-K 1 vsci20130516_8k.htm FORM 8-K vsci20130516_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported):   May 12, 2013

 

VISION-SCIENCES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-20970

 

13-3430173

(State or other jurisdiction

 

(Registration Number)

 

(IRS Employer

of incorporation)

 

Identification No.)

 

Identification No.)

 

 

40 Ramland Road South

Orangeburg, NY

 

 

10962

(Address of principal executive offices)

 

(Zip Code)

 

 

Registrant’s telephone number, including area code:  (845) 365-0600

 

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

  

ITEM 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

 (b)

On May 12, 2013, Mr. Keith Darragh, the Company’s Vice President of Finance, Principal Financial Officer and Principal Accounting Officer, indicated his intention to leave the Company to pursue other opportunities, effective May 17, 2013. The Company has initiated a search for a replacement.

 

Mr. Darragh’s departure was not the result of any disagreement with the Company or its auditors over accounting principles or practices, financial statements, or other matters.

 

   

 

 

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Vision-Sciences, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

VISION-SCIENCES, INC.

 

 

 

 

 

 

 

By:

/s/ Howard Zauberman

 

 

Name:

Howard Zauberman

 

 

Title:

Interim Chief Executive Officer

 

 

Date:  May 16, 2013

 

 

3